Effects of vitamin D on insulin resistance in type two diabetic patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138811073216N1

Enrollment

217

Registered

2010-08-25

Start date

2008-12-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes

Interventions

vit D tab 50000 unit oral one month.

Treatment - Drugs

vit D tab 50000 unit oral one month

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Absence of hepatic, renal, bone disease, Not receiving anticonvulsant drugs, calcium, anticancer drugs and vitamin D

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Insulin resistance. Timepoint: Immediately befor intervention and 1 Month after intervention. Method of measurement: HOMA-IR with Blood glucose and Insulin.	—

Secondary

Measure	Time frame
Fasting Blood Sugar. Timepoint: 1 month. Method of measurement: Laboratory methods.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Talaei

Arak medical university

talaiei.a@arakmu.ac.ir+98 86 1222 5229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026